The Global Digestive Enzyme Supplements Market will Hit $1.5 Billion by 2028, at a CAGR of 7.7%

Digestive Enzyme Supplements Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Digestive Enzyme Supplements Market size is expected to reach $1.5 billion by 2028, rising at a market growth of 7.7% CAGR during the forecast period.

The Additional supplements acquired maximum revenue share in dominated the Global Digestive Enzyme Supplements Market by Application in 2021 thereby, achieving a market value of $946.4 Million by 2028. Increasing adult and high awareness of weight reduction and maintaining a healthy lifestyle is anticipated to positively affect the market for digestive enzyme supplements.

The Microbial segment has shown the growth rate of 9.2% during (2022 - 2028). Fermented microbes, such as fungi and bacteria, like Aspergillus oryzae as well as Aspergillus niger, are the source of microbial enzymes. Microbes that have undergone fermentation have a wide range of pH, temperature, and substrate preferences. Additionally, during the forecast period, the demand for these enzymes would be fueled by their abundant availability across a broad spectrum of enzymatic functions and their lower manufacturing costs compared to animal enzymes.

The North America market dominated the Global Digestive Enzyme Supplements Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $530.3 Million by 2028. The Asia Pacific market is exhibiting a CAGR of 8.6% during (2022 - 2028). Additionally, The Europe market would showcase a CAGR of 7% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/digestive-enzyme-supplements-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ProThera, Inc., Enzymes, Inc., AST Enzymes, Vemo 99 Ltd., Zeus Biotech Pvt. Ltd., Metagenics, Inc., Xymogen, HVL, LLC, Ortho Molecular Products, Inc., and Enzymedica, Inc.

Global Digestive Enzyme Supplements Market Segmentation

By Application

• Additional supplements
• Medical & Infant Nutrition
• Sports Nutrition

By Origin

• Animal
• Plant
• Microbial
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• ProThera, Inc.
• Enzymes, Inc.
• AST Enzymes
• Vemo 99 Ltd.
• Zeus Biotech Pvt. Ltd.
• Metagenics, Inc.
• Xymogen
• HVL, LLC
• Ortho Molecular Products, Inc.
• Enzymedica, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

North America Digestive Enzyme Supplements Market size & Opportunities 2022-2028

Europe Digestive Enzyme Supplements Market & Growth Forecast 2022-2028

Asia Pacific Digestive Enzyme Supplements Market Share & Industry Outlook to 2028

LAMEA Digestive Enzyme Supplements Market Growth, Trends & Forecasts 2022-2028